RUNX3 and adenocarcinoma: Ito et al. recently reported that RUNX3 knockout mice (Balb/c background) showed loss of chief cells and development of SPEM, and also displayed higher susceptibility to adenocarcinoma by treatment with MNU [201], supporting a role for RUNX3 as a tumor suppressor of gastric cancer.